You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anaplastic Astrocytoma (AA)

Showing 1 - 25 of 1,164
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Super-Selective Intraarterial Intracranial Infusion of

Completed
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Super-Selective Intraarterial Intracranial Infusion of Temozolomide
  • New York, New York
    Lenox Hill Brain Tumor Center
Mar 2, 2021

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)

Active, not recruiting
  • Anaplastic Astrocytoma
  • Recurrent Anaplastic Astrocytoma
  • Birmingham, Alabama
  • +78 more
Jan 19, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

Active, not recruiting
  • Astrocytoma
  • Glioblastoma
  • Jacksonville, Florida
  • +8 more
Dec 14, 2022

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed
Has Results
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
Dec 28, 2022

IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

Terminated
Has Results
  • IDH Family Wildtype
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)

Suspended
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Bevacizumab and Carboplatin
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Loupe-Based Intraoperative Fluorescence Imaging

    Recruiting
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
      • Lexington, Kentucky
        University of Kentucky
      Mar 3, 2022

      Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

      Not yet recruiting
      • Recurrent High Grade Glioma
      • +4 more
      • (no location specified)
      Jan 24, 2023

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

      Terminated
      Has Results
      • Glioblastoma Multiforme
      • +3 more
      • Indianapolis, Indiana
        Riley Hospital for Children at IU Health
      Jul 21, 2022

      Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))

      Completed
      Has Results
      • Brain Tumor
      • +4 more
      • Zotiraciclib (TG02)
      • Temozolomide (TMZ)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 3, 2021

      Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

      Recruiting
      • Anaplastic Astrocytoma, IDH-Wildtype
      • +8 more
      • Quality-of-Life Assessment
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 8, 2022

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

      Not yet recruiting
      • Glioblastoma Multiforme
      • +4 more
      • SIACI of cetuximab and bevacizumab
      • Miami, Florida
        Jackson Memorial Hospital
      Jul 14, 2023

      Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

      Withdrawn
      • Recurrent Anaplastic Astrocytoma
      • +7 more
      • Neural Stem Cells-expressing CRAd-S-pk7
      • Resection
      • (no location specified)
      Nov 22, 2022

      Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

      Recruiting
      • Diffuse Astrocytoma
      • +22 more
      • Phoenix, Arizona
      • +26 more
      Jan 27, 2023

      Glioblastoma, Anaplastic Astrocytoma Trial in Houston (ADV/HSV-tk (gene therapy))

      Recruiting
      • Glioblastoma
      • Anaplastic Astrocytoma
      • ADV/HSV-tk (gene therapy)
      • Houston, Texas
        Houston Methodist Neurological Institute
      Sep 3, 2020

      Brain Cancer, MALIGNANT GLIOMA, Glioblastoma Trial in United States (Bevacizumab & Stereotactic Radiotherapy)

      Completed
      • Brain Cancer
      • +7 more
      • Bevacizumab & Stereotactic Radiotherapy
      • San Francisco, California
      • +4 more
      Nov 20, 2019

      Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

      Recruiting
      • Recurrent High-grade Glioma
      • +3 more
      • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
      • +2 more
      • Incheon, Korea, Republic of
        Gachon University Gil Medical Center
      Feb 19, 2023

      CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

      Recruiting
      • Central Nervous System Neoplasms
      • +22 more
      • Bethesda, Maryland
        National Institutes of Health
      Mar 1, 2022

      Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

      Active, not recruiting
      • Glioblastoma Multiforme of Brain
      • +2 more
      • C134
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Sep 19, 2022